New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Regeneron Pharmaceuticals, Inc.
REGN
Shape
US Flag

NASDAQ

77B

Biotechnology

Next Earning date - 01 May 2025

77B

Biotechnology

Next Earning date - 01 May 2025

709.53USD

Shape-12.54 ( -1.74%)
Market Closed (as of Feb 08, 00:51 EDT)
favorite-chart

Relative Strenght

17
favorite-chart

Volume Buzz

-9%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated February 8, 2025
1W 6.47 % 1M 1.88 % 3M -14.01 % 1Y -25.53 %

Key Metrics

Shape
  • Market Cap

    76.68B


  • Shares Outstanding

    108.07M


  • Share in Float

    105.91M


  • Dividende

    0


  • Earning Date

    01 May 2025


  • Price Target

    709.5285


  • Average Volume

    894898


  • Beta

    0.142


  • Range

    642-1211.2


  • Industry

    Biotechnology


  • Website

    https://www.regeneron.com


  • Sector

    Healthcare


Fundamentals

Shape

15.56x

P/E Ratio

5.49x

P/S Ratio

2.22x

P/B Ratio

0.1

Debt/Equity

31.1%

Net Margin

$38.3

EPS

How REGN compares to sector?

P/E Ratio

Relative Strength

Shape

REGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$15B

Shape285%

2025-Revenue

$43.42

Shape409%

2025-EPS

$6B

Shape523%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Citigroup

initialise

Previous: Not converted

2024-11-13

Now: Neutral

Leerink Partners

downgrade

Previous: Not converted

2024-09-24

Now: Market Perform

Evercore ISI

initialise

Previous: Not converted

2024-05-13

Now: Outperform

RBC Capital

upgrade

Previous: Underperform

2024-01-12

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+13%

10.09
vs 8.93

Q2.23

arrow
arrow

+5%

10.24
vs 9.77

Q3.23

arrow
arrow

+4%

11.59
vs 11.14

Q4.23

arrow
arrow

-6%

11.86
vs 12.56

Q1.24

arrow
arrow

-5%

9.55
vs 10.09

Q2.24

arrow
arrow

+13%

11.56
vs 10.24

Q3.24

arrow
arrow

+8%

12.46
vs 11.59

Q4.24

arrow
arrow

+2%

12.07
vs 11.86

Q1.25

arrow
arrow

+2%

9.72
vs 9.55

Q2.25

arrow
arrow

-7%

10.77
vs 11.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+7%

3.2B  vs 3B

Q2.23

arrow
arrow

+11%

3.2B  vs 2.9B

Q3.23

arrow
arrow

+15%

3.4B  vs 2.9B

Q4.23

arrow
arrow

+1%

3.4B  vs 3.4B

Q1.24

arrow
arrow

-1%

3.1B  vs 3.2B

Q2.24

arrow
arrow

+12%

3.5B  vs 3.2B

Q3.24

arrow
arrow

+11%

3.7B  vs 3.4B

Q4.24

arrow
arrow

+10%

3.8B  vs 3.4B

Q1.25

arrow
arrow

+9%

3.4B  vs 3.1B

Q2.25

arrow
arrow

+2%

3.6B  vs 3.5B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+3%

0.03
vs 0.05

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.04

Q4.23

arrow
arrow

+4%

0.04
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.04

Q2.24

arrow
arrow

+5%

0.05
vs 0.03

Q3.24

arrow
arrow

+5%

0.05
vs 0.05

Q4.24

arrow
arrow

+3%

0.03
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

1203

1.2K
vs 1.1K

7%

Q1.23

arrow
arrow

1241

1.2K
vs 1.2K

3%

Q2.23

arrow
arrow

1214

1.2K
vs 1.2K

-2%

Q3.23

arrow
arrow

1232

1.2K
vs 1.2K

1%

Q4.23

arrow
arrow

1321

1.3K
vs 1.2K

7%

Q1.24

arrow
arrow

1365

1.4K
vs 1.3K

3%

Q2.24

arrow
arrow

1378

1.4K
vs 1.4K

1%

Q3.24

arrow
arrow

1437

1.4K
vs 1.4K

4%

Earnings Growth

Latest News